C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 205/04 (2006.01) A61K 31/395 (2006.01) A61P 11/06 (2006.01) A61P 11/08 (2006.01) A61P 29/00 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2479266
Compounds of formula (I) in free or salt form, wherein Ar, X, Y, R1, R2, R3, R5, m, n, p, and q have the meanings as indicated in the specification, are useful for treating conditions mediated by CCR3. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
L'invention a trait à des composés représentés par la formule (I), sous forme libre ou sous forme de sel, où Ar, X, Y, R?1¿, R?2¿, R?3¿, R?5¿, m, n, p, et q sont tels que définis dans le descriptif. Lesdits composés sont utiles au traitement d'états pathologiques induits par CCR3. L'invention concerne également des compositions pharmaceutiques contenant lesdits composés, et des procédés de préparation desdits composés.
Le Grand Darren Mark
Mccarthy Clive
Walker Clive Victor
Woods John James
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Azetidine derivatives as ccr-3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azetidine derivatives as ccr-3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azetidine derivatives as ccr-3 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2006427